> ViewRay launched a prospective clinical trial for its MRI-guided radiation therapy system in locally advanced unresectable pancreatic cancer. Release | Read more about ViewRay
> Boston Scientific is rolling out its suite of MRI-conditional Resonate implantable cardioverter defibrillators. Release
> Novocure announced data from a phase 3 study showing that patients with newly diagnosed glioblastoma who underwent a combination treatment of its Optune device and the chemo drug temozolomide fared better than those who received temozolomide alone. Release
